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Introduction: Computed tomography screening can detect lung can-
cer that is curable. However, some studies demonstrated that the risk 
for false-positives was about 50%. To make screening more efficient, 
we sought to create a forecasting model for individuals with different 
risks for lung cancer.
Methods: We used multiple logistic regression analysis to identify 
independent predictors and to develop a prediction model. The path-
ological diagnoses in Guangdong Lung Cancer Institute were con-
secutively chosen as probands. All first-degree relatives of probands 
and their spouses were included as subjects. We divided the probands 
and their spouses into three subgroups according to the odds ratios 
(ORs), and the accuracy of lung cancer predictions for patients within 
the subgroups increased synchronously.
Results: There were 633 proband pedigrees and 565 spouse pedigrees. 
Independent predictors of lung cancer included sex (OR, 1.6; 95% 
confidence interval [CI], 1.1–2.3), smoking history (light smoker: OR, 
1.1; 95% CI, 0.7–1.8; heavy smoker: OR, 4.7; 95% CI, 3.1–7.1), lung 
disease history (OR, 5.3; 95% CI, 2.8–10.0), occupational exposure 
(OR, 1.6; 95% CI, 1.1–2.2), and number of affected individuals among 
first-degree relatives (n = 1: OR, 2.1; 95% CI, 1.3–3.4; n ≥ 2: OR, 4.7; 
95% CI, 0.5–41.2). The accuracy of the pretest probability increased 
for those with higher ORs: low-OR subgroup, 68.3%; mid-OR sub-
group, 84.0%; and high-OR subgroup, 91.9%.
Conclusions: Our prediction rule is recommended for estimating the 
pretest probability of lung cancer, thereby facilitating early screening.
Key Words: Lung cancer, Statistical model, Diagnosis, Screening, 
Pulmonary.
(J Thorac Oncol. 2012;7: 1534-1540)
Lung cancer is an aggressive and heterogeneous disease.1,2 Advances in multidetector computed tomography (CT) have 
made high-resolution volumetric imaging possible in a single 
breath hold at acceptable levels of radiation exposure,3 allowing 
its use for certain lung-specific applications. The National Lung 
Screening Trial (NLST), a randomized trial of screening using 
low-dose CT compared with screening using chest radiography, 
suggested that screening using low-dose CT reduced mortality 
from lung cancer.4 However, the false-positive rates were very 
high (approximately 95%) in both groups, probably because 
of chronic inflammation in the lungs associated with smoking. 
This suggests the need to carefully select patients for screening.
From 1993 to 2005, the Early Lung Cancer Action 
Project (ELCAP) began a study on the early diagnosis of lung 
cancer in cigarette smokers, using annual screening with spiral 
CT.5 Among the 302 participants with clinical stage I cancer, 
who underwent surgical resection within 1 month after diag-
nosis, the survival rate was 92% (prostate, lung, colorectal, and 
ovarian) (95% confidence interval [CI], 88–95). However, for 
an individual in the PLCO cancer screening trial, the risk of a 
false-positive finding was approximately 50% or greater.6
An important early step in the management of annual 
spiral CT screening is to estimate the clinical pretest probabil-
ity of lung cancer. Intuitively, management should be more 
aggressive when the pretest probability is higher and more 
conservative when the pretest probability is lower. In this way, 
screening should be more efficient.
PATIENTS AND METHODS
This was a clinic-based study. All participants provided 
informed consent. The study protocol was approved by the 
Institutional Review Board.
Participants
Between October 2009 and December 2010, this cohort 
study enrolled 633 patients whose origins represented 25 of 
the 33 provincial administrative regions in China. Those with 
pathological diagnoses of lung cancer at Guangdong Lung 
Cancer Institute were chosen as the probands. All first-degree 
relatives of the probands and their spouses were brought in 
as study subjects. These pedigrees consisted of 633 proband 
pedigrees and 565 spouse pedigrees. Spouses and their 
first-degree relatives were excluded if spouses had cancer 
diagnosed, they were divorced or dead for more than 3 years, 
or the proband was unmarried.
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Variables
We collected information about age, sex, race, stage, 
lung disease history, living environment, occupational expo-
sure, smoking history, and the number of affected individuals 
as first-degree relatives. The same investigator interviewed the 
patients and their spouses using the unified genetic epidemio-
logical survey. To reduce possible recall bias, we confirmed 
uncertain answers through the probands or their relatives by 
telephone. The reference group was made up of the probands’ 
spouses.
The living environment was supplemented by detailed 
questions on cooking practices, fuel use, housing character-
istics, and whether they lived in a polluted industrial zone. 
The selection of intensity was classified as never, light, and 
heavy. Analogously, the questions about occupational expo-
sure included whether they usually had contact with dust, 
asbestos, radioactive material, and volatile chemicals for each 
work period of at least 1 year during the subject’s lifetime. We 
determined the living environment or occupational exposure 
as positive if any of the selections was heavy.
Statistical Analyses
We used available data from this study to develop and 
internally validate a model of pretest probability. We devel-
oped the model using step-wise logistic regression with the 
diagnosis of lung cancer as the dependent variable and the 
following independent variables: age cohort (< 50/≥ 50 years), 
sex (female/male), lung disease history (never/ever), liv-
ing environment (never/ever), occupational exposure (never/
ever), smoking history (never/< 20 pack-years/≥ 20 pack-
years), and number of affected individuals as first-degree 
relatives (0/1/≥ 2). Using backward selection, we arrived at 
a final parsimonious model by eliminating variables that were 
not statistically significant at a level of 0.05. All clinically 
plausible interactions were tested, but none were statistically 
significant; thus, they were not included in the final model. 
We report odds ratios (ORs) and 95% CIs for statistically sig-
nificant predictors.
We used the Hosmer–Lemeshow goodness-of-fit statis-
tic (p > 0.05) to evaluate model fit.7,8 We used the final model 
to calculate the estimated probability of lung cancer in each 
study participant. We then compared the predicted probabil-
ity of lung cancer with the final diagnosis and constructed a 
receiver operating characteristic curve. To describe the accu-
racy of the model for identifying lung cancer in the study par-
ticipants, we report the area under the curve (AUC) and its 
95% CI.9
We divided the study cohort into three subgroups 
according to their ORs compared with the general Chinese 
population: subgroup A—subjects with ORs of less than 5; 
subgroup B—subjects with ORs of at least 5, but less than 10; 
subgroup C—subjects with ORs of 10 and higher. Then, we 
analyzed the accuracy of lung cancer prediction for patients in 
each subgroup using logistic discriminant analysis.10
We internally validated the model using a resampling 
or cross-validation procedure, enabling use of the full data 
set for model development.11 To do this, we divided the 
study population into 10 equal groups by sampling randomly 
without replacement. For each group, we generated the pre-
dicted probability of metastasis using parameters that were 
estimated from a logistic regression model using data from 
the other nine groups. These 10 logistic regressions had iden-
tical specifications, and each used 90% of the data. We then 
calculated the AUC for the probabilities generated by the 
cross-validation.
RESULTS
Possible Influencing Factors
The characteristics of the 633 probands and 565 
spouses are described in Table 1. The mean age was 
59.0 ± 11.3 years in the case arm and 57.7 ± 11.3 years in the 
control arm (Fig. 1). There were 426 patients with adenocar-
cinoma, 107 patients with squamous carcinoma, 54 patients 
with small-cell lung cancer, and 46 patients with other types 
of lung cancer. The statistically significant characteristics 
were sex, smoking history, lung disease history, and occu-
pational exposure. Living environment was not significant at 
a level of 0.05, possibly because the couples lived together. 
However, we still introduced it into the model as an indepen-
dent variable.
According to the number of affected individuals among 
the first-degree relatives of the probands and spouses, the 
pedigrees were divided into three groups: 0, 1, and 2 or more 
affected individuals (Table 2). As can be seen, apart from one 
subgroup with a small sample size in the control arm, the rest 
showed statistically significant differences. Therefore, we 
also introduced this factor into the model as an independent 
variable.
Independent Predictors of Lung 
Cancer in the Model
Familial aggregation of lung cancer has been reported 
in various populations since 1963.12–16 Several studies12–14,17,18 
have shown that relatives of individuals with lung cancer are 
at an increased risk for the disease, even after adjusting for 
individual risk factors. These studies suggest that familial 
clustering of lung cancer may be influenced by not only shared 
environmental factors but also shared genes. Furthermore, 
some studies have indicated that early-onset lung cancer 
seems to be heritable and probably the result of a highly pen-
etrant recessive gene or genes that predispose to tobacco car-
cinogens.19–21 We took a stratified approach with age cohort 
(<50 versus ≥50 years; Table 3), and introduced this into the 
model as an independent variable.
We identified five independent predictors of lung cancer 
using multivariate logistic regression analysis (Table 4). The 
other potential predictors examined were not associated with a 
diagnosis of lung cancer and thus were not included in the final 
model. Men had a risk that was approximately 60% higher than 
that in women (OR, 1.60; 95% CI, 1.13–2.26). Light smokers 
seemed to have an increased risk, approximately 10% higher 
than never-smokers (OR, 1.11; 95% CI, 0.69–1.78), whereas 
heavy smokers had a risk of approximately five times that of 
never-smokers (OR, 4.72; 95% CI, 3.13–7.13). The likelihood 
of lung cancer increased more than fivefold for those with a 
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lung disease history (OR, 5.33; 95% CI, 2.84–10.02) and by 
approximately 60% for those with an occupational exposure 
history (OR, 1.59; 95% CI, 1.13–2.23). Compared with 
the likelihood of lung cancer in subjects with no affected 
first-degree relative, the likelihood of lung cancer in those 
with one affected first-degree relative was approximately 
twofold (OR, 2.1; 95% CI, 1.28–3.43). The likelihood of lung 
cancer in those with two or more affected first-degree relatives 
was more than fourfold, although there was no statistical 
difference(OR, 4.67; 95% CI, 0.53–41.18). This might be 
because the sample size in the control group was just one.
Parsimonious Clinical Prediction Equation
The clinical prediction model is described by the fol-
lowing equations:
Probability of lung cancer = ex/(1 + ex) (1)
X = −0.784 + (0.467 × sex) + (0.106 × smoke
1
) + 
(1.552 × smoke
2
) + (1.674 × lung disease) + (0.462 × occu-
pational exposure) + (0.740 × N
1
) + (1.541 × N
2
) (2)
where e is the base of the natural logarithm, smoke
1
 is 1 
for light smoker/0 for others, smoke
2
 is 1 for heavy smoker/0 
for others, lung disease is 1 for a lung disease history/0 for 
no history, occupational exposure is 1 for an occupational 
exposure history/0 for no history, N
1
 is 1 for one affected 
individual among first-degree relatives, N
2
 is 1 for two or more 
affected individuals among first-degree relatives.
When this model was used for prediction, we corrected 
the constant to estimate the pretest probability of lung cancer 
in the unconditional logistic regression model:
α= α′− ln (
n q
n q
1 0
0 1
) (3)
where n1 and n0 are the sample numbers in the case arm 
and control arm, respectively; q1 is 49.7/100,000, which is 
TABLE 1. Epidemiology Data Comparison
Characteristic
Case 
(n = 633)
Control 
(n = 565) p
Age (yrs) mean ± SD 59.0 ± 11.3 57.7 ± 11.3 0.045
Age cohort (yrs) n (%) n (%)
 <50 125 (19.7) 136 (24.1) 0.070
  ≥50 508 (80.3) 429 (75.9)
Sex
 Male 411 (64.9) 185 (32.7) <0.001
 Female 222 (35.1) 380 (67.3)
Smoking history, pack-years
 0 276 (43.6) 446 (78.9) <0.001
 <20 59 (9.3) 56 (9.9)
 ≥20 298 (47.1) 63 (11.2)
Lung disease history
 Never 547 (86.4) 552 (97.7) <0.001
 Ever 86 (13.6) 13 (2.3)
Living environment
 Never 527 (83.3) 481 (85.1) 0.374
 Ever 106 (16.7) 84 (14.9)
Occupational exposure
 Never 477 (75.4) 489 (86.5) <0.001
 Ever 156 (24.6) 76 (13.5)
Values are given as number (percentage), except for age.
FIGURE 1. Distribution of age in the 
case and control arms.
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the a priori probability of lung cancer in the general Chinese 
population;22 and q0 is equal to one minus q1.
In the prediction model, the risk compared with that 
in the general Chinese population ranged from 0.41-fold to 
121.31-fold (Table 5).23 Goodness-of-fit testing with the like-
lihood ratio and Hosmer–Lemeshow tests showed that the 
model accounted for the outcome better than chance alone 
(p < 0.01) and that the predicted likelihood of the outcome 
was similar to the observed likelihood (p = 0.62). A correla-
tion matrix of parameter estimates revealed little evidence of 
multicollinearity.
The accuracy of the model was good, with an AUC of 
0.75 (95% CI, 0.72–0.78). The predicted probabilities gen-
erated with the cross-validation procedure showed a similar 
AUC (0.71; 95% CI, 0.68–0.74). Using logistic discrimi-
nant analysis, the accuracy of the pretest probability was 
68.3% in subgroup A, 84.0% in subgroup B, and 91.9% in 
subgroup C.
DISCUSSION
In 2004, the Genetic Epidemiology of Lung Cancer 
Consortium conducted a genome-wide linkage analysis of 52 
extended pedigrees, ascertained through probands with lung 
cancer who had several first-degree relatives with the same 
disease. The results localized a major susceptibility locus influ-
encing lung cancer risk to 6q23–25. Furthermore, the relative 
increase in the estimated proportion of linked families in subsets 
of families with an increasing number of affected individuals 
suggested a decrease in heterogeneity in the more informative 
families.24 Thus, we analyzed subgroups based on the number 
of affected individuals among the first-degree relatives of the 
probands and spouses (0, 1, and ≥2), and the number of affected 
individuals among first-degree relatives was included as an 
TABLE 2.  Odds Ratios of Risk for Lung Cancer by History of 
Lung Cancer among First-Degree Relatives
Factor Case/Control
Crude OR 
(95% CI)
Adjusted OR 
(95% CI)
Family history
 No 560/534 1.00 1.00
 Yes 73/31 2.25 
(1.45, 3.47)
2.20 
(1.36, 3.55)
n of pedigrees with
 0 560/534 1.00 1.00
 1 65/30 2.07 
(1.32, 3.24)
2.11 
(1.29, 3.44)
 ≥2 lung cancers 8/1 7.63 
(0.95, 1.20)
4.49 
(0.51, 39.27)
aAdjusted ORs calculated by conditional logistic regression adjusted for sex, lung 
disease history, smoking index, living environment, and occupational exposure.
OR, odds ratio; CI, confidence interval.
TABLE 3. Risk for Lung Cancer Stratified by Age Cohort
Age 
Cohort 
(yrs) Factor
Case/Control 
n/n
Crude OR 
(95% CI)
Adjusted ORa 
(95% CI)
<50 Family history No 108/129 1.00 1.00
Yes 17/7 2.90 
(1.16, 7.25)
2.44 
(0.91, 6.55)
n of pedigrees with 0 108/129 1.00 1.00
1 15/7 2.56 
(1.01, 6.51)
2.09 
(0.75, 5.82)
≥ 2 lung cancers 2/0 — —
≥50 Family history No 452/405 1.00 1.00
Yes 56/24 2.09 
(1.27, 3.44)
2.22 
(1.28, 3.85)
n of pedigrees with 0 452/405 1.00 1.00
1 50/23 1.95 
(1.17, 3.25)
2.23 
(1.27, 3.92)
≥ 2 lung cancers 6/1 5.38 
(0.64, 4.84)
2.15 
(0.24, 19.57)
aORs calculated by conditional logistic regression adjusted for sex, lung disease history, smoking index, living environment, and occupational exposure.
CI, confidence interval; OR, odds ratio.
TABLE 4, Predictors of Lung Cancer
Predictor OR 95% CI
Sex 1.60 1.13–2.26
Smoking history
 Light smoker 1.11 0.69–1.78
 Heavy smoker 4.72 3.13–7.13
Lung disease history 5.33 2.84–10.02
Occupation expose 1.59 1.13–2.23
n of affected individuals among 
first-degree relatives
 n = 1 2.10 1.28–3.43
 n ≥ 2 4.67 0.53–41.18
CI, confidence interval; OR, odds ratio.
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TABLE 5. Prediction of Lung Cancer Morbidity and Risk
Row
Sex
Lung 
Disease 
History
Occupation 
Exposure 
History
Light 
Smoker
Heavy 
Smoker
Affected 
Individuals 
(n = 1)
Affected 
Individuals 
(n ≥ 2) Constant
p ORa0.467 1.674 0.462 0.106 1.552 0.740 1.541 −0.784
1 0 0 0 0 0 0 0 0.000203 0.41
2 0 0 0 1 0 0 0 0.000225 0.45
3 0 0 1 0 0 0 0 0.000321 0.65
4 1 0 0 0 0 0 0 0.000323 0.65
5 0 0 1 1 0 0 0 0.000357 0.72
6 1 0 0 1 0 0 0 0.000359 0.72
7 0 0 0 0 0 1 0 0.000425 0.85
8 0 0 0 1 0 1 0 0.000472 0.95
9 1 0 1 0 0 0 0 0.000513 1.03
10 1 0 1 1 0 0 0 0.000570 1.15
11 0 0 1 0 0 1 0 0.000674 1.36
12 1 0 0 0 0 1 0 0.000677 1.36
13 0 0 1 1 0 1 0 0.000749 1.51
14 1 0 0 1 0 1 0 0.000753 1.51
15 0 0 0 0 0 0 1 0.000946 1.90
16 0 0 0 0 1 0 0 0.000956 1.92
17 0 0 0 1 0 0 1 0.001051 2.12
18 1 0 1 0 0 1 0 0.001075 2.16
19 0 1 0 0 0 0 0 0.001080 2.17
20 1 0 1 1 0 1 0 0.001195 2.40
21 0 1 0 1 0 0 0 0.001201 2.42
22 0 0 1 0 0 0 1 0.001501 3.02
23 1 0 0 0 0 0 1 0.001509 3.04
24 0 0 1 0 1 0 0 0.001518 3.05
25 1 0 0 0 1 0 0 0.001525 3.07
26 0 0 1 1 0 0 1 0.001669 3.36
27 1 0 0 1 0 0 1 0.001677 3.37
28 0 1 1 0 0 0 0 0.001715 3.45
29 1 1 0 0 0 0 0 0.001723 3.47
30 0 1 1 1 0 0 0 0.001906 3.84
31 1 1 0 1 0 0 0 0.001916 3.85
32 0 0 0 0 1 1 0 0.002004 4.03
33 0 1 0 0 0 1 0 0.002264 4.56
34 1 0 1 0 0 0 1 0.002395 4.82
35 1 0 1 0 1 0 0 0.002421 4.87
36 0 1 0 1 0 1 0 0.002517 5.07
37 1 0 1 1 0 0 1 0.002662 5.36
38 1 1 1 0 0 0 0 0.002735 5.50
39 1 1 1 1 0 0 0 0.003041 6.12
40 0 0 1 0 1 1 0 0.003181 6.40
41 1 0 0 0 1 1 0 0.003197 6.43
42 0 1 1 0 0 1 0 0.003594 7.23
43 1 1 0 0 0 1 0 0.003612 7.27
44 0 1 1 1 0 1 0 0.003996 8.04
45 1 1 0 1 0 1 0 0.004016 8.08
46 0 0 0 0 1 0 1 0.004465 8.98
47 0 1 0 0 0 0 1 0.005044 10.15
48 1 0 1 0 1 1 0 0.005074 10.21
(Continued)
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independent predictor of lung cancer in the final model. This 
suggests a genetic influence on the risk for lung cancer.
CT screening can detect early-stage lung cancer in a 
high proportion of subjects, but it is associated with a high 
rate of false-positive results. The false-positive rates were very 
high in the NLST (approximately 95%) and the PLCO cancer 
screening trial (≥ 50%). In the present study, we used available 
data to develop and internally validate a new model for esti-
mating pretest probability that may help guide the selection 
of the high-risk group. We identified five independent predic-
tors of lung cancer: sex, smoking history, lung disease history, 
occupational exposure, and number of affected individuals 
among first-degree relatives. Importantly, we developed a par-
simonious clinical prediction equation that estimates patient-
specific probability of lung cancer with very good accuracy 
and excellent calibration. In our model, the accuracy of the 
pretest probability was 68.3% in subgroup A, 84.0% in sub-
group B, and 91.9% in subgroup C. If we select people with 
ORs of at least 5 for screening, the risk of a false-positive find-
ing may be much lower than in the earlier studies.
The participants in the ELCAP trial were asymptomatic.5 
The participants in the PLCO cancer screening trial met the 
selection criterion of 55 to 74 years of age.6 In the NLST 
trial, eligible participants were between 55 and 74 years of 
age at the time of randomization, had a history of cigarette 
smoking of at least 30 pack-years, and if a former smoker, had 
quit within the previous 15 years.4 As in these earlier studies, 
smoking history played an important role in our model. 
However, our model also included sex, lung disease history, 
occupational exposure, and number of affected individuals 
among first-degree relatives as independent predictors of 
lung cancer. Unlike the PLCO and NLST trials, our study 
did not demonstrate that older people were at a higher risk 
than younger people, because age cohort was not included as 
an independent predictor of lung cancer in the final model. 
Although the rows were ordered by OR estimates, we could 
see the effect of an individual variable on the risk estimates. 
Lung cancer was more closely linked to those with higher 
ORs, so the accuracy of their pretest probability was higher 
than accuracy of probability in those with lower ORs.
TABLE 5. (Continued)
Sex
Lung 
Disease 
History
Occupation 
Exposure 
History
Light 
Smoker
Heavy 
Smoker
Affected 
Individuals 
(n = 1)
Affected 
Individuals 
(n ≥ 2) Constant
Row 0.467 1.674 0.462 0.106 1.552 0.740 1.541 −0.784 p ORa
49 0 1 0 0 1 0 0 0.005100 10.26
50 0 1 0 1 0 0 1 0.005608 11.28
51 1 1 1 0 0 1 0 0.005733 11.53
52 1 1 1 1 0 1 0 0.006374 12.82
53 0 0 1 0 1 0 1 0.007086 14.26
54 1 0 0 0 1 0 1 0.007122 14.33
55 0 1 1 0 0 0 1 0.008006 16.11
56 1 1 0 0 0 0 1 0.008046 16.19
57 0 1 1 0 1 0 0 0.008095 16.29
58 1 1 0 0 1 0 0 0.008135 16.37
59 0 1 1 1 0 0 1 0.008901 17.91
60 1 1 0 1 0 0 1 0.008946 18.00
61 0 1 0 0 1 1 0 0.010689 21.51
62 1 0 1 0 1 0 1 0.011304 22.75
63 1 1 1 0 0 0 1 0.012771 25.70
64 1 1 1 0 1 0 0 0.012912 25.98
65 1 1 1 1 0 0 1 0.014199 28.57
66 0 1 1 0 1 1 0 0.016966 34.14
67 1 1 0 0 1 1 0 0.017051 34.31
68 0 1 0 0 1 0 1 0.023812 47.91
69 1 1 1 0 1 1 0 0.027064 54.45
70 0 1 1 0 1 0 1 0.037796 76.05
71 1 1 0 0 1 0 1 0.037985 76.43
72 1 1 1 0 1 0 1 0.060291 121.31
aPrediction for study subject with lung cancer morbidity compared with the general Chinese population.
bThis table included 72 kinds of combinations extended by the three equations described in the text, in which variables were assigned values so we could see individual risk on 
the risk estimates. For example, if a man, without lung disease history or occupation expose history, is a heavy smoker and has one affected individual in first-degree relatives, he 
should be the case in row 41 and his OR is 6.43.
OR, odds ratio.
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McMahon et al.25 showed that annual screening of cur-
rent and former smokers aged between 50 and 74 years costs 
$126,000 to $1,69,000 per quality-adjusted life-year gained 
($/QALY) (minimum 20 pack-years of smoking) or $110,000 
to $166,000/QALY (40 pack-year minimum), as compared 
with no screening and assuming background quit rates. 
Although beneficial, screening had a higher cost per QALY 
when the model included radiation-induced lung cancers. We 
showed that the accuracy of the pretest probability increased 
in those with higher ORs, which suggests that the effective-
ness and cost-effectiveness of strategies for CT screening in 
lung cancer may depend critically on the pretest probability of 
lung cancer. Our prediction equation may be used to facilitate 
clinical decision making regarding the selection and interpre-
tation of CT screening for lung cancer. The equation could 
also be incorporated into a formal decision analysis or cost-
effectiveness analysis.
Our study has several limitations. This study col-
lected little information about the severity of living envi-
ronment, occupational exposure, and lung disease history. 
Consequently, additional predictors of lung cancer remain 
unidentified. Our results require external validation in an 
independent cohort of patients and then it would be possible 
to collect more detailed information to improve the current 
model. This model was developed in Chinese people and may 
be particularly well suited for use in this patient population 
only. The applicability of the model to other populations is 
unknown. Although living environment was not included 
in the final model, it should be considered before making 
clinical decisions. Furthermore, because the accuracy of the 
model is likely to depend on the prevalence of lung cancer in 
the target population, it may not be well calibrated for use in 
populations with a lower or higher prevalence of lung can-
cer compared with that in our study population. However, we 
believe that the prevalence of lung cancer in our study popu-
lation is fairly representative of other groups, as we strove to 
reduce selection bias by enrolling all probands consecutively 
in 1 year.
Despite the very good accuracy of the model, we empha-
size that it is not intended to be used as a standalone test, but 
rather as a tool to help guide the selection and interpretation 
of subsequent diagnostic tests.
This model showed greater value in people at higher 
risk. We conclude that the pretest probability of lung cancer 
can be estimated using a parsimonious clinical prediction 
equation, which may facilitate clinical decision making.
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